The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?

There is no doubt that solar ultraviolet (UV) exposure is the most important environmental risk factor for the development of non-melanoma skin cancer. Therefore, sun protection is of particular importance to prevent these malignancies, especially in risk groups. However, 90% of all requisite vitamin D has to be formed in the skin through the action of the sun-a serious problem, for a connection between vitamin D deficiency and a broad variety of independent diseases including various types of cancer, bone diseases, autoimmune diseases, hypertension and cardiovascular disease has now been clearly indicated in a large number of epidemiologic and laboratory studies. An important link that improved our understanding of these new findings was the discovery that the biologically active vitamin D metabolite 1,25(OH)(2)D is not exclusively produced in the kidney, but in many other tissues such as prostate, colon, skin and osteoblasts. Extra-renally produced 1,25(OH)(2)D is now considered to be an autocrine or paracrine hormone, regulating various cellular functions including cell growth. We and others have shown that strict sun protection causes vitamin D deficiency in risk groups. In the light of new scientific findings that convincingly demonstrate an association of vitamin D deficiency with a variety of severe diseases including various cancers, the detection and treatment of vitamin D deficiency in sun-deprived risk groups is of high importance. It has to be emphasized that in groups that are at high risk of developing vitamin D deficiency (e.g., nursing home residents or patients under immunosuppressive therapy), vitamin D status has to be monitored. Vitamin D deficiency should be treated, e.g., by giving vitamin D orally. Dermatologists and other clinicians have to recognize that there is convincing evidence that the protective effect of less intense solar UV radiation outweighs its mutagenic effects. Although further work is necessary to define an adequate vitamin D status and adequate guidelines for solar UV exposure, it is at present mandatory that public health campaigns and recommendations of dermatologists on sun protection consider these facts. Well-balanced recommendations on sun protection have to ensure an adequate vitamin D status, thereby protecting people against adverse effects of strict sun protection without significantly increasing the risk of developing UV-induced skin cancer.

[1]  Suzanne M Olbricht,et al.  Cutaneous squamous cell carcinoma. , 2008, Advances in dermatology.

[2]  S. Peller CARCINOGENESIS AS A MEANS OF REDUCING CANCER MORTALITY , 1936 .

[3]  D. Battistutta,et al.  Incidence and determinants of skin cancer in a high‐risk australian population , 1990, International journal of cancer.

[4]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[5]  M. Kligman Biologic Effects of Light , 1992 .

[6]  G. Schwartz Vitamin D and the Big Three: Cancers of the Colon, Breast, and Prostate , 2002 .

[7]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. I. Importance of host factors , 1988, International journal of cancer.

[8]  M. Holick,et al.  Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas. , 1999, The American journal of pathology.

[9]  E. Meese,et al.  Analysis of the vitamin D system in basal cell carcinomas (BCCs) , 2004, Laboratory Investigation.

[10]  C. Garland,et al.  Sunlight and breast cancer incidence in the USSR. , 1990, International journal of epidemiology.

[11]  B. Boucher Sunlight “D”ilemma , 2001, The Lancet.

[12]  E. Baron The Immune System and Nonmelanoma Skin Cancers , 2006 .

[13]  Bruce K. Armstrong,et al.  Sun exposure and non-melanocytic skin cancer , 1994, Cancer Causes & Control.

[14]  P. Hutchinson,et al.  Vitamin D and systemic cancer: is this relevant to malignant melanoma? , 2002, The British journal of dermatology.

[15]  J. Elwood,et al.  Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.

[16]  K. Margolin Sun exposure and mortality from melanoma , 2006 .

[17]  L. Potter,et al.  A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma , 2004, British Journal of Cancer.

[18]  C. Garland,et al.  Can colon cancer incidence and death rates be reduced with calcium and vitamin D? , 1991, The American journal of clinical nutrition.

[19]  J. Reichrath Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas , 2006 .

[20]  J. Bouwes Bavinck,et al.  The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. , 2003, The Journal of investigative dermatology.

[21]  J. Reichrath,et al.  No evidence for amplification of 25-hydroxyvitamin D-1α-OHase (1α-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma (MM) , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  M. Holick,et al.  Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness , 2001, The Lancet.

[23]  J. Reichrath,et al.  A plea for the analysis of Vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS) , 2004, Cancer Causes & Control.

[24]  J. Reichrath,et al.  25-hydroxyvitamin D deficiency in renal transplant recipients. , 2006, The Journal of clinical endocrinology and metabolism.

[25]  R. Vieth,et al.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. , 1999, The American journal of clinical nutrition.

[26]  T. Chen,et al.  Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  J. Reichrath,et al.  Vitamin D and skin: new aspects for dermatology , 2004, Experimental dermatology.

[28]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.

[29]  J. Reichrath,et al.  Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  H. Olsson,et al.  Is the use of sunscreens a risk factor for malignant melanoma? , 1995, Melanoma research.

[31]  D Ratner,et al.  Cutaneous squamous-cell carcinoma. , 2001, The New England journal of medicine.

[32]  M. Jänner,et al.  Histopathologie der Hautkrankheiten , 1982 .

[33]  C. Garland,et al.  SERUM 25-HYDROXYVITAMIN D AND COLON CANCER: EIGHT-YEAR PROSPECTIVE STUDY , 1989, The Lancet.

[34]  J. Reichrath,et al.  Analysis of the vitamin D system in cutaneous squamous cell carcinomas , 2004, Journal of cutaneous pathology.

[35]  B. Dawson-Hughes,et al.  Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. , 1995, The American journal of clinical nutrition.

[36]  W. Grant An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet‐B radiation , 2002, Cancer.

[37]  T. Diepgen,et al.  The Epidemiology of Basal Cell and Squamous Cell Carcinoma , 2006 .

[38]  M. Holick Evolution and function of vitamin D. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[39]  J. Reichrath,et al.  Histology of Epithelial Skin Tumors , 2006 .

[40]  J. Coebergh,et al.  A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. , 2005, European journal of cancer.

[41]  R. Stern,et al.  Nonmelanoma cancers of the skin. , 1992, The New England journal of medicine.

[42]  C. Frost,et al.  Epidemiology of solar keratoses , 1994, The British journal of dermatology.

[43]  U. Fischer,et al.  Vitamin D3 Metabolism in Human Glioblastoma Multiforme: Functionality of CYP27B1 Splice Variants, Metabolism of Calcidiol, and Effect of Calcitriol , 2005, Clinical Cancer Research.

[44]  Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. , 1992 .

[45]  P. Lips,et al.  Estimates of optimal vitamin D status , 2005, Osteoporosis International.

[46]  B. Armstrong,et al.  The epidemiology of UV induced skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.

[47]  F. Apperly The Relation of Solar Radiation to Cancer Mortality in North America , 1941 .

[48]  B. Gilchrest,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[49]  J. Moan,et al.  Solar radiation, vitamin D and survival rate of colon cancer in Norway. , 2005, Journal of photochemistry and photobiology. B, Biology.

[50]  L. M. Dzubow Basal cell carcinomas. , 1986, Plastic and reconstructive surgery.

[51]  J. Reichrath Will Analogs of 1,25-Dihydroxyvitamin D3 (Calcitriol) Open a New Era in Cancer Therapy? , 2001, Oncology Research and Treatment.

[52]  K. Rass UV Damage and DNA Repair in Basal Cell and Squamous Cell Carcinomas , 2006 .

[53]  J. Reichrath,et al.  Ultraviolet light (UV)‐induced immunosuppression: Is vitamin D the missing link? , 2003, Journal of cellular biochemistry.

[54]  V. Siskind,et al.  Geographical distribution of cutaneous melanoma in Queensland , 1983, The Medical journal of Australia.

[55]  J. Mark Elwood,et al.  Melanoma and sun exposure: An overview of published studies , 1997, International journal of cancer.

[56]  T. Mack,et al.  The pathogenesis of melanoma induced by ultraviolet radiation. , 1999, The New England journal of medicine.

[57]  Andrew G Smith,et al.  Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  M. Wolter,et al.  Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas , 2005, The British journal of dermatology.